Actavis to launch generic Celebrex

|By:, SA News Editor

Actavis (ACT) confirms that it will launch its generic Celebrex product in May after yesterday's favorable court ruling invalidating Pfizer's (PFE) patent.

The FDA must approval its Abbreviated New Drug Application before commercialization commences.

Celebrex generated $2.2B in US sales last year.